Adventist Health System Sunbelt Healthcare Corporation

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Prospective Evaluation of the Clinical Utility of Peroral Endoscopic Myotomy for Gastrointestinal Motility Disorders

Recruiting

Conditions: Esophageal Spasm, Diffuse
Swallowing Disorder
Zenker Diverticulum
Achalasia
Gastroparesis

First Posted Date: 2023-06-15

Last Posted Date: 2024-04-25

Lead Sponsor: AdventHealth

Target Recruit Count: 600

Registration Number: NCT05905016

Locations: 🇺🇸
AdventHealth Orlando, Orlando, Florida, United States

Targeting Network Dysfunction in Apathy of Late-life Depression Using Digital Therapeutics

Not Applicable

Not yet recruiting

Conditions: Apathy
Major Depressive Disorder

Interventions: Behavioral: General Cognitive Training Intervention
Behavioral: Targeted Cognitive Training Intervention

First Posted Date: 2023-05-26

Last Posted Date: 2024-12-18

Lead Sponsor: AdventHealth

Target Recruit Count: 84

Registration Number: NCT05877885

Locations: 🇺🇸
AdventHealth Neuroscience Institute, Orlando, Florida, United States
🇺🇸
Lauren Elizabeth Oberlin, Orlando, Florida, United States

Evaluation of the Clinical Utility of Endoscopic Closure Using a Dual Action Tissue (DAT) Clip

Recruiting

Conditions: Perforation Colon
Perforated Bowel
Fistula
Perforation Duodenal
GI Bleeding
Perforation Bowel

First Posted Date: 2023-05-10

Last Posted Date: 2024-05-01

Lead Sponsor: AdventHealth

Target Recruit Count: 250

Registration Number: NCT05852457

Locations: 🇺🇸
AdventHealth Orlando, Orlando, Florida, United States
🇺🇸
Parkview Health, Fort Wayne, Indiana, United States

Self-Assembling Matrix Forming Gel to Prevent Stricture Formation

Active, not recruiting

Conditions: Esophageal Stricture
Stricture

Interventions: Device: Purastat SAP gel application

First Posted Date: 2022-10-14

Last Posted Date: 2024-08-09

Lead Sponsor: AdventHealth

Target Recruit Count: 41

Registration Number: NCT05581173

Locations: 🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
🇺🇸
Johns Hopkins, Baltimore, Maryland, United States
🇺🇸
Parkview, Fort Wayne, Indiana, United States

and more 3 locations

Phase II Trial of Lurbinectedin Combined With Avelumab as Switch Maintenance Firstline Therapy

Phase 2

Withdrawn

Conditions: Metastatic Cancer
Urothelial Carcinoma

Interventions: Drug: avelumab (PD-L1 inhibitor immunotherapy) + lurbinectedin

First Posted Date: 2022-10-10

Last Posted Date: 2024-08-01

Lead Sponsor: AdventHealth

Registration Number: NCT05574504

Locations: 🇺🇸
AdventHealth Cancer Institute, Orlando, Florida, United States

Endoscopic Submucosal Dissection (ESD)

Recruiting

Conditions: Esophageal Lesion
Barrett Esophagus
Gastrointestinal Lesions

First Posted Date: 2022-07-21

Last Posted Date: 2023-10-25

Lead Sponsor: AdventHealth

Target Recruit Count: 1000

Registration Number: NCT05468008

Locations: 🇺🇸
AdventHealth Orlando, Orlando, Florida, United States

BioDFence® G3 For Full Nerve-Sparing Robotic-Assisted Radical Prostatectomy

Phase 3

Withdrawn

Conditions: Prostatectomy
Prostate Cancer
Erectile Dysfunction Following Radical Prostatectomy
Incontinence, Urinary

Interventions: Biological: BioDFence G3

First Posted Date: 2022-05-06

Last Posted Date: 2023-06-29

Lead Sponsor: AdventHealth

Registration Number: NCT05363644

Locations: 🇺🇸
AdventHealth, Celebration, Florida, United States

Hybrid Versus Non-Hybrid Endoscopic Submucosal Dissection for Colorectal Polyps (SHORT-ESD)

Not Applicable

Completed

Conditions: Colorectal Lesions

Interventions: Procedure: Hybrid ESD
Procedure: Non-hybrid ESD

First Posted Date: 2022-04-26

Last Posted Date: 2024-12-20

Lead Sponsor: AdventHealth

Target Recruit Count: 247

Registration Number: NCT05347446

Locations: 🇺🇸
University of Florida, Gainesville, Florida, United States
🇺🇸
AdventHealth Orlando, Orlando, Florida, United States
🇺🇸
Parkview, Fort Wayne, Indiana, United States

and more 2 locations

Stromal Vascular Fraction (SVF) Cells for Non-Operative Treatment of Small Rotator Cuff Tears

Phase 2

Withdrawn

Conditions: Rotator Cuff Tears

Interventions: Drug: Tisseel Injectable Product
Biological: Stromal Vascular Fraction Cells

First Posted Date: 2022-03-03

Last Posted Date: 2023-02-15

Lead Sponsor: AdventHealth

Registration Number: NCT05264922

Locations: 🇺🇸
AdventHealth Orlando, Orlando, Florida, United States

RISE RCT for Nurse Leaders

Not Applicable

Completed

Conditions: Stress
Burnout

Interventions: Behavioral: RISE for Nurse Leaders Program

First Posted Date: 2022-02-24

Last Posted Date: 2023-06-28

Lead Sponsor: AdventHealth

Target Recruit Count: 80

Registration Number: NCT05254600

Locations: 🇺🇸
AdventHealth Orlando, Orlando, Florida, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy